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The  repor t  by  Shaw et al. (1954) on the  effec-  
t iveness  of  Meg imide  (be ta -be ta -methy l -e thy l -g lu ta -  
r imide - -  Bemegr ide  - -  Miked imide)  as a b a r b i t u r a t e  
an t agon i s t ,  led to the  E u r o p e a n  use of  th i s  compound  
as an  ac t i va t i ng  a g e n t  in clinical  electroencephalo- 
g raphy .  I n  p r e l im i na ry  repor ts  severa l  au thors ,  Delay 
et al. (1956) ,  Coi raul t  et al. (1956) ,  and  Cour jon  and  
B o n n e t  (1956) ,  were f avo rab ly  impressed  wi th  the  use  
of  Meg imide  as an  E E G  ac t iva t i ng  agent .  A l t h o u g h  
Cour jon  and  B o n n e t  s t a ted  t h a t  Meg imide  was  not  
a lways  as e f f i c i en t  as Metrazol ,  all i nves t iga to r s  
seemed to note  a be t t e r  to lerance and  more  gent le  
act ion.  Drossopoulo et al. (1956) ,  concluded t h a t  Me- 
g imide  ac t iva t ion  was  super ior  to Met razo l  because  of 
less d i sagreeable  side e f fec ts ,  E E G  changes  were less 
ab rup t ,  pa r t i a l  seizures t h a t  m a y  be set o f f  were 
less l iable to become general ized,  and  d rug  seizures 
more  closely resembled  spon taneous  ones. A less 
f avorab le  repor t  by  } , lodmark et al. (1957) ind ica ted  
p ronounced  s imi la r i ty  be tween  Metrazol  and  Megi-  
mide ac t iva t ion  especial ly in respect  to sub jec t ive  diz- 
ziness, anxie ty ,  and  nausea .  I n  th i s  coun t ry  the  use  
of  Meg imide  as an  ac t i va t i ng  agen t  was repor ted  by  
Green and  } ' ink (1957) .  T hey  sugges t ed  t h a t  the  
d rug  appea red  to be s imi la r  in act ion to ]~Ietrazol on 
psych ia t r i c  pa t i en t s .  
The p re sen t  s t udy  was  u n d e r t a k e n  to eva lua te  the  
re la t ive e f f i cacy  of  the  two d rugs  in m a n  and  in 
expe r imen ta l  an ima l s  and  to tes t  the  above observa-  
t ions  t h a t  Meg imide  is subjec t ive ly  be t t e r  to le ra ted  
by the  pa t i en t  t h a n  Metrazol .  
} , i f teen chronic  schizophrenic  pa t i en t s ,  5 chronic 
epileptic pa t i en t s ,  and  5 no rma l  vo lunteers  were 
examined .  The  pa t i en t s  were t aken  o f f  all med ica t ions  
for  a per iod of  a t  leas t  48 hours  pr ior  to the  tests .  
There  was  a u sua l  m i n i m u m  of  one week and  a 
m a x i m u m  of one yea r  be tween Metrazol  and  Meg imide  
t es t s  on each subjec t .  I n  some pa t i en t s  Met razo l  was 
the  f i r s t  d rug  used,  in o thers  i t  was  Megimide .  In-  
t r avenous  Met razo l  was  in jec ted  a t  the  ra te  of  50 mg.  
per  min.  to 750 mg.  or un t i l  E E G  ac t iva t ion  or a 
clinical  seizure occurred.  The  Meg imide  procedure  was  
to r ap id ly  in jec t  20 mg.  i n t r avenous ly  followed by 
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5 rag. every 15 see. to a to ta l  of  250 mg.  or unt i l  
?~EG ac t iva t ion  or a clinical  seizure developed. 
I t  was  a p p a r e n t  in all th ree  g roups  of sub jec t s  t h a t  
the  resu l t s  of  the  ac t i va t i ng  procedures  were com- 
parab le  unde r  the  two drugs .  Two records are  shown 
in f i gu re  1. I f  an  indiv idual ,  i r respect ive  of diag-  
nosis,  was  ac t iva ted  by Metrazol ,  ac t iva t ion  occurred 
in a s imi la r  f a sh ion  wi th  Megimide .  Likewise,  i f  no 
change  was  seen wi th  Megimide  there  was  also none 
with Metrazol .  One schizophrenic  pa t i en t  was  excep- 
t ional  i n a s m u c h  as no ac t iva t ion  had  occurred one 
yea r  ear l ier  wi th  500 mg.  of  Met razol  while 70 mg.  
of  Meg imide  produced  a typ ica l  spike-wave responses .  
I t  is possible  t h a t  the  long in te rva l  be tween  tes t s  
m i g h t  be responsible  for  th i s  resul t ,  a l t hough  in one 
other  case of  schizophrenia ,  wi th  an  equal ly  long 
in t e r -d rug  interval ,  E E G  changes  unde r  the  d rugs  
were comparable .  
The type  of d i scharges  induced  by  e i ther  d rug  
was qui te  var iable .  H i g h  vo l tage  p a r o x y s m a l  dis- 
charges ,  a typ ica l  spike-waves,  and  focal  ac t iva t ion ,  
especial ly of  the  t empora l  areas ,  were mos t  common.  
Slowing of the  back-g round  r h y t h m s  to a 5-7 c /sec .  
was  observed less f requent ly .  T h o u g h  there  were la rge  
in te r - ind iv idua l  va r i a t ions  bo th  d rugs  induced  E E G  
changes  which seemed to be specif ic  for  the  individual .  
Fo r  example ,  a pa t i en t  would no t  respond wi th  a focal  
t empora l  d i scharge  to Metrazol  and  wi th  an  a typ ica l  
spike-wave bu r s t  to Megimide  or vice versa.  F i g u r e s  1 
and  2 represen t  typ ica l  examples .  The  except ion to 
th i s  resul t  was t h a t  twice out  of  25 compar i sons  
Megimide  ac t iva t ion  m a n i f e s t e d  i t se l f  in i t ia l ly  by  
h igh  vol tage  pa roxysma l  d ischarges ,  while Metrazol  
led to a typ ica l  spike-wave burs t s .  Th i s  would s u g g e s t  
a mi lder  ac t ion  of  Megimide .  However ,  in 6 ins t ances  
Megimide  produced  a typ ica l  spike-wave b u r s t s  as the  
f i r s t  ind ica t ion  of ac t iva t ion ,  as did Metrazol .  
No overt  seizures were seen wi th  e i ther  d rug  in 
two epilept ics  bu t  E E G  ac t iva t ion  occurred wi th  
500 mg.  of  1Vfetrazol. Two h u n d r e d  and  f i f t y  mg.  of  
Meg imide  produced  s imi la r  E E G  ac t iva t ion  and  like- 
wise no over t  seizures.  The  3 o ther  epi lept ics  re- 
sponded wi th  seizures to bo th  drugs .  These  a t t acks  
were of  the  g r a n d  mal  va r i e ty  and  the  wa rd  a t t e n d a n t  
s t a t ed  they  were typica l  fo r  the  pa r t i cu l a r  pa t i en t .  
There  were no clinical d i f f e rences  be tween Metrazol  
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and Megimide seizures especially not in terms of 
duration or mildness. 
Two of the 5 normal subjects had discharges with 
both drugs, 2 failed to activate with either, and one 
who had such a profound spinning sensation with 
350 rag. of Metrazol that  the procedure was stopped, 
showed a spike-wave paroxysm under 180 rag. of 
Megimide. 
The 20 schizophrenic and epileptic patients were 
largely uncommunicative and no statements could be 
to the pre-activation level in the normaIs and psy- 
chiatric patients. Activation of the EEG persisted 
longer in the epileptic group but at  no time was 
barbiturate fast  activity observed. I t  was generally 
found that  one-half to one-fifth of the rag. dose 
needed for Metrazol activation sufficed in producing 
Megimide changes. This apparent advantage of Megi- 
mide is somewhat offset  by the fact  that  i t  is com- 
mercially available only in a 0.5 per cent solution 
while Metrazo] is prepared in a 5 or 10 per cent con- 
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elicited concerning side effects of either drug. All 
normals reported similar subjective sensations from 
both drugs but under Megimide the sensations were 
less intense. With Megimide no subject reported a 
'c f u n n y "  smell or taste which was often observed 
during Metrazol administration. Amytal (150 rag. i.v.) 
af ter  Megimide, led to a rapid disappearance of the 
subjective discomfort as well as a return of the EEG 
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Examples of individual responses to Metrazol and Meglmide in schizophrenic patients. 
centration. One may thus have to inject, e.g. ,  40 ce. 
of fluid in order to reach effects comparable to 8 ce. 
of Metrazol. 
Five acute cat preparations were employed for  
further tests of the relative effectiveness of EEG 
activation with the drugs. Under ether, bipolar elec- 
trodes were stereotactically inserted into the ventral 
lateral nucleus of the thalamus, caudate nucleus, hippo- 
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campus ,  and  re t icu la r  f o r m a t i o n  of  the  m i d b r a i n  and  
ros t ra l  medul la ,  a l t hough  all of  these  were not  s tud ied  
in each an imal .  Su r face  electrodes on the  cerebral  and  
eerebel lar  cortex were screw-type.  Al l  e lectrodes were 
f ixed  and  in su l a t ed  wi th  den ta l  acrylic and  incised 
t i ssues ,  ear  regions,  etc. were procainized.  A f t e r  an- 
and  a ha l f  hours  they  were observed unde r  i n t r avenous  
Megimide  induced  seizures.  The  other  3 received Me- 
g imide  f i r s t  and  1Ketrazol la ter .  Convu l san t  Meg imide  
doses r a n g e d  f r o m  5 to 10 m g / k g ,  depend ing  on 
ra te  of  in jec t ion ,  Met razo l  20 to 30 m g / k g .  I n  all 
ins tances  there  were no apprec iab le  qua l i t a t ive  dif-  





L F - L M  ~ 
RF-RM 
L M - L O  
RM -RO 
L T - L M  
RT-RM 
L T - L O  
R T - R O  
7 - 2 6 - 5 7  AGE46 
MEGIMIDE IO5MGM 
RESTING RECORD 
3 ~ T  
L F - L M  
R F - R M  
L M - L O  
RM-RO 
L T ° L M  
RT- RM 
L ' r - L  0 ~ - =  
RT-RO 
METRAZOL 450M GM 
J B  10-15- 56  AGE45 I S£CONDJ 
so~wt 
Fig. 2 
Examples of individual responses to Metrazol and Megimide in schizophrenic patients. 
es thes ia  wore o f f  the  an ima l s  were immobi l ized  wi th  
F laxedi l  a n d  m a i n t a i n e d  on a r t i f i c i a l  resp i ra t ion .  
Elec t r ica l  record ings  were made  wi th  a Grass  8-channel  
E E G  machine .  Seizures  were p rec ip i t a t ed  by  slow 
in t r avenous  in jec t ion  of  Met razo l  (20 rag. every  rain.)  
in 2 ca ts  and  fo l lowing a recovery per iod  of  one 
ferences  be tween the types  of  seizure d i scharges  ob- 
served wi th  the  two d rugs  ( f ig .  3) nor  was  there  
evidence t h a t  l~eg imide  seizures were shor te r  in  dura-  
t ion. 
F i g u r e  4 shows t h a t  the  f i r s t  change  in  the  elec- 
t r ica l  ac t iv i ty  a t  a preeonvuls ive  level occurred with 
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Comparison of Metrazol and Megtmide seizures in the acute cat  preparation.  The tracings on the first 
channel  reflect recordings between the midbrain ret icular  formation and the left cerebellar hemisphere. 
The other channels record bipolar from the s tructures  indicated. The large dose of Metrazol is due to extremely 
slow drug administration.  The cal ibrat ion signals represent 50 ftV. Please note the different amplifications used. 
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Acute cat  preparat ion,  bipolar  recordings. The nuclear  s t ructures  of the tha lamus  sampled were not identical 
on the two sides. The tip of the left electrode was found to be in n. ventr, post. lat . ,  the tip of the r ight 
electrode in n. ventr, post. reed. Calibration signals 100 and 200 /~V. respectively. 
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Megimide in the cortex. The subcortical structures 
studied fired only af te r  there had been seizure ac- 
t ivity established in the cortex. This effect  was also 
observed with slow i.v. injection of Metrazol and is in 
agreement with Starzl et El. (1954). A fur ther  
similarity between Metrazol and Megimide was the 
observation tha t  s tatus epilepticus which was induced 
at the end of 3 experiments with Megimide could be 
promptly controlled by intravenous administrat ion of 
a 5 per cent solution of Tridione. 
Drug comparisons in the eat were extended to 3 
chronic preparat ions with permanently implanted 
screw type electrodes in frontal,  auditory, and visual 
areas of the cerebral cortex, and in both eerebellar 
hemispheres. The pre-seizure buildup and the seizures 
themselves were similar under both drugs in spite of 
the fact  tha t  Metrazol was given subcutaneously while 
Megimide had to be administered intraperi toneally 
because of i ts  weak concentration. A eonvulsant dose 
of Megimide was found to be between 17 and 20 
mg/kg. ,  whereas tha t  of Metrazol was 40 to 50 mg/kg .  
In  one animal  the electrical seizure activity was 
slightly more lateralized to one side of the brain  
under Megimide while i t  appeared more symmetrical 
with Metrazol. The voltage of these seizure discharges 
was about one-third less during the Megimide con- 
vulsion. All 3 cats evidenced qualitatively similar be- 
havior during the preseizure buildup with both drugs. 
In i t ia l  meowing was followed by urination,  defecation, 
panting,  piloerection, twitching, salivation, and finally 
massive jerking.  Although all of these responses also 
occurred with Megimide, there appeared to be a 
quanti tat ive difference, i.e., the meowing was in 
general not as loud and as persistent,  the pant ing  was 
less vigorous, and there was more twitching ra ther  
than massive jerking.  In  these respects the observa- 
tions suggest tha t  Megimide may have a milder action 
than Metrazol. 
CONCLUSIONS 
The results obtained in this study confirm the 
observations reported in the l i terature,  tha t  Megimide 
and Metrazol produce essentially comparable effects 
clinically and electroencephalographically. There is 
also a suggestion tha t  Megimide gives rise to some- 
what  less intense subjective sensations than is the 
general rule with Metrazol and it  may be in some 
instances milder in i ts electroeneephalographie effect. 
When Megimide is used for diagnostic purposes in pa- 
t ients suspected of having convulsive disorders i t  will, 
however, be necessary to employ the same caution in 
interpret ing the f indings tha t  one has to use in 
regard to Metrazol findings, since i t  is quite apparent  
tha t  some non-epileptic " n o r m a l "  volunteers, may 
also show electroencephalographic activation at  low 
levels of the drug. 
Megimide was kindly supplied for this investigation 
by A. and G. Nicholas Inc., N.Y. The project  was in 
par t  supported by USPHS Grant  No. 1379 and B-1068. 
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